Difference between revisions of "Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 12 in DOI: 10.1016/j.clim.2020.108427 (Q11255)"
Jump to navigation
Jump to search
(Created claim: Eighteenth Author string (P166): Raoult D, #quickstatements; #temporary_batch_1593105010297) |
(Created claim: title (P93): Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, #quickstatements; #temporary_batch_1593105300644) |
||
| Property / title | |||
| + | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (English) | ||
| Property / title: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (English) / rank | |||
| + | Normal rank | ||
Revision as of 17:15, 25 June 2020
Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 12 in DOI: 10.1016/j.clim.2020.108427
|
Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.
|
Statements
Int J Antimicrob Agents
0 references
2020
0 references
Gautret P
0 references
Lagier JC
0 references
Parola P
0 references
Hoang VT
0 references
Meddeb L
0 references
Mailhe M
0 references
Doudier B
0 references
Courjon J
0 references
Giordanengo V
0 references
Vieira VE
0 references
Dupont HT
0 references
Honore S
0 references
Colson P
0 references
Chabriere E
0 references
La Scola B
0 references
Rolain JM
0 references
Brouqui P
0 references
Raoult D
0 references
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (English)
0 references
